Weifa is Norway's leading fully-integrated pharmaceutical company. We supply real value through medicines, lifestyle products and solutions that address the essential needs of consumers, customers and professional partners.
Weifa was founded in 1940 and now employs about 180 highly qualified people at our headquarters in Oslo and production plants in Kragerø. Sales are increasing steadily, reaching NOK 500 million in 2012, an 8 per cent increase from 2011.
The company has a strong position in Norway and is the market leader in pain relief, with well-established brands such as Paracet and Ibux. We are also present in other key areas such as dietary supplements and treatment for colds and respiratory problems. Weifa also has a considerable international business and is a leading producer of active ingredients for diabetes medicine (metformin) and opiates for use in pain relief and cough medicine. 40 per cent of our turnover comes from our international business, where our customers are leading global pharmaceutical companies.